ClearPoint Neuro adds to executive lineup

By The Science Advisory Board staff writers

January 27, 2021 -- ClearPoint Neuro said that Ernesto Salegio, PhD, will be joining its biologics and drug delivery team as vice president and segment leader for translational and preclinical research.

Salegio comes to ClearPoint Neuro with over 19 years of experience in translational neuroscience, including over 16 years of gene therapy experience working with adeno-associated viral vectors. The appointment is effective March 1.

ClearPoint Neuro launched its biologics and drug delivery team in 2020 to provide a range of services for pharmaceutical and academic partners working on gene and stem cell therapies for the brain, according to the firm.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.